NCT05808244

Brief Summary

This mixed-method study aims to examine the feasibility of delivering tgCBFI programme to dyads of people with schizophrenia and their family caregivers, and generate preliminary evidence on the effectiveness of tgCBFI in reducing expressed emotion. The research questions are as follows.

  1. 1.What are the feasibility, acceptability, and safety of conducting a tele-group CBFI programme for people with schizophrenia and their family caregivers?
  2. 2.What effect does tgCBFI have on the expressed emotion experienced by adults with schizophrenia and the caregiving experience of their family caregivers at posttreatment and 12-week after completion of the programme?
  3. 3.What effect does tgCBFI have on the positive and negative symptoms of adults with schizophrenia and the perceived care burden and level of mood disturbance of their family caregivers at posttreatment, and 12-week after completion of the programme?

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable schizophrenia

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable schizophrenia

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

April 1, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 11, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

April 11, 2023

Status Verified

March 1, 2023

Enrollment Period

9 months

First QC Date

March 29, 2023

Last Update Submit

March 29, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Level of service satisfaction of service users and family caregivers

    Immediate posttreatment

  • Feasibility, acceptability, and safety of the programme

    Throughout the whole programme

Secondary Outcomes (5)

  • Perceived expressed emotion of service users

    up to 12-week follow up

  • Positive and negative symptoms of service users

    up to 12-week follow up

  • Mood disturbance of family caregivers

    up to 12-week follow up

  • Perceived care burden of family caregivers

    up to 12-week follow up

  • Qualitative feedback from service users and family caregivers

    Immediate posttreatment

Study Arms (2)

tgCBFI

EXPERIMENTAL
Behavioral: tgCBFIBehavioral: Usual psychiatric care

Usual psychiatric care

ACTIVE COMPARATOR
Behavioral: Usual psychiatric care

Interventions

tgCBFIBEHAVIORAL

Six weekly sessions CBT-based family intervention programme

tgCBFI

Integrated community psychiatric care with medical follow-up

Usual psychiatric caretgCBFI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Service users
  • diagnosis of schizophrenia-spectrum disorders, based on ICD-10 made by the treating clinicians
  • aged 18 to 64
  • able to communicate in Cantonese
  • Family caregivers
  • aged 18 or above
  • able to communicate in Cantonese
  • live with service users

You may not qualify if:

  • Service users
  • have co-morbidity of learning disability, organic/neurological conditions, or substance misuse disorder
  • live in hostel
  • Family caregivers
  • have active psychiatric conditions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

SchizophreniaPsychotic Disorders

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Central Study Contacts

Dennis Chak Fai Ma

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate (Mental Health)

Study Record Dates

First Submitted

March 29, 2023

First Posted

April 11, 2023

Study Start

April 1, 2023

Primary Completion

January 1, 2024

Study Completion

February 1, 2024

Last Updated

April 11, 2023

Record last verified: 2023-03